Search clinical trials for: AFFITOPE® PD01A

Total 13780 results

Affiris AG
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Completed

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA (AFF009)

Neurodegenerative Diseases | Multiple System Atrophy

France
Affiris AG

Completed

Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA)

Parkinson's Disease

Austria
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease

Parkinson's Disease

Austria
Affiris AG
Medical University Innsbruck; Forschungszentrum Juelich; PROSENEX AmbulatoriumbetriebsGMBH

Completed

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease (AFF011)

Parkinson Disease | Neurodegenerative Diseases

Austria
Affiris AG

Completed

Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008A)

Parkinson's Disease

Austria
Affiris AG
University Hospital Tuebingen

Withdrawn

Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients

Parkinson's Disease

Germany
Affiris AG
Medical University of Vienna

Completed

Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects (AFF012)

Hypercholesterolemia

Austria
Affiris AG

Terminated

Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006

Alzheimer´s Disease

France, Austria, Croatia, Czech Republic, Germany, Slovakia
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Austria
Affiris AG

Completed

Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease

Alzheimer's Disease

France, Austria, Croatia, Germany, Czech Republic, Slovakia
Affiris AG

Completed

Safety and Tolerability of AFFITOPE AD03 (MimoVax)

Alzheimer's Disease

Austria
Affiris AG

Completed

Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02

Alzheimer's Disease

Austria
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Austria
Maastricht University Medical Center

Completed

The Effect of PD01 on Cardiovascular Health and Microbial Environment

Obesity | Overweight

Netherlands
Galderma R&D

Completed

Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis

Atopic Dermatitis

Philippines, China
Dong-A ST Co., Ltd.

Completed

A Study to Demonstrate the Efficacy and Safety of Motilitone®

Functional Dyspepsia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

Healthy

Korea, Republic of
Chung-Ang University Hosptial, Chung-Ang University...

Unknown

A Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia

Functional Dyspepsia

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immune Response of Different Pediatric Combination Vaccines.

Pertussis | Diphtheria | Polio

United States
Amir Azarpazhooh
Institut Straumann AG

Completed

Effect of Emdogain® on Soft Tissue Wound Healing

Periodontal Inflammation | Crown Lengthening

Canada
Novartis Pharmaceuticals

Completed

Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices

Pulmonary Disease, Chronic Obstructive (COPD)

Argentina
Guerbet

Completed

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors (REMIND)

Primary Brain Tumor

Colombia, Korea, Republic of, United States, Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines

Pertussis

United States
University of Miami
BSN Medical Inc

Recruiting

VLU Dressing Study

Venous Leg Ulcer

United States
University Hospital, Caen

Completed

Incidence of Dual Mobility Polyethylene Wear in Total Hip Prosthesis. Randomised Study Versus Fixed Insert by Radiostereometric Analysis. (DOUMOB)

Total Hip Replacement
Coopervision, Inc.

Completed

Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal (INNOVATION)

Presbyopia
Tufts University

Completed

Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials

Alveolar Bone Loss

United States
Assistance Publique Hopitaux De Marseille

Completed

Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask. (Mask)

Lung Cancer | Brain Metastases

France
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

Cystic Fibrosis

Czechia, Moldova, Republic of, Slovakia
Hoffmann-La Roche

Completed

A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)

Chronic Renal Anemia

Belgium, Brazil, United Kingdom, Serbia, Spain, Germany, Korea, Republic of, Turkey, Lithuania, Italy, Czechia, Argentina, Australia, Croatia, France, Greece, Israel, Malaysia, Mexico, Panama, Philippines, Poland, Russian Federation, ... and more
Global Kinetics Corporation

Terminated

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG (TARGET-PD)

Parkinson Disease

United States
Global Kinetics Corporation

Withdrawn

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG (TARGET-PwP)

Parkinson Disease
CereVasc Inc
AlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...

Terminated

Pilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating Hydrocephalus

Hydrocephalus | Hydrocephalus, Communicating

United States
University of Baghdad

Completed

Evaluating Implant Stability Using Three Devices Osstell®, Periotest® and AnyCheck®

Edentulous Alveolar Ridge

Iraq
Novo Nordisk A/S

Completed

A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

Healthy | Growth Disorder

United States
Guangzhou Institute of Respiratory Disease

Completed

Carbon Dioxide Rebreathing During Exercise Assisted by Non-invasive Ventilation

Pulmonary Disease, Chronic Obstructive

China
nthalmic Pty Ltd
Brighten Optix Corporation

Recruiting

S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children

Myopia

India, Spain, China
Lument AB

Terminated

A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

Subjects Referred to CT-examination of the Abdomen

Sweden
W.L.Gore & Associates

Completed

GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry

Aortic Diseases | Aortic Aneurysm, Thoracic | Penetrating Ulcer | Descending Thoracic Aortic Dissection | Aorta Thoracic; Traumatic Rupture

France
Revance Therapeutics, Inc.

Active, not recruiting

Teosyal RHA® Histology and Intradermal Implantation Evaluation Study

Histology

Canada
Tufts University

Completed

Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft (Mucograft)

Tooth Extraction Status Nos
Almirall, S.A.
Forest Laboratories

Completed

Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, United Kingdom
Ascensia Diabetes Care

Completed

Comparison Evaluation of Blood Glucose Meter Systems

Diabetes

United States
CVRx, Inc.

Completed

Rheos System for the Treatment of HFpEF Heart Failure (HOPE4HF)

Heart Failure

United States
Université de Montréal

Completed

Peri-Implant Healing Around Two Different Machined-Collar Designs After 25 Years of Function

Jaw, Edentulous

Canada
University of Oxford

Completed

A Study of the Interaction Between BCG And MenC Immunisation: BAM (BAM)

Immune Response | BCG Infection | Reaction - Vaccine

United Kingdom
W.L.Gore & Associates

Suspended

GORE® VIABIL® Biliary Endoprosthesis in the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis (VIABILITY)

Pancreatitis, Chronic | Stricture; Bile Duct

United States
Guerbet

Completed

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography (X-ACT)

Coronary Artery Disease

Spain, France, Germany, Italy, Switzerland
Novartis Pharmaceuticals

Completed

Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure (ASTRONAUT)

Acute Decompensated Heart Failure | Congestive Heart Failure

Colombia, Czech Republic, India, Italy, Belgium, Turkey, Argentina, France, Germany, Israel, Spain, Canada, Taiwan, United States, Singapore, Russian Federation, Philippines, Slovakia, Sweden, Hungary, Finland, Poland, Romania, Brazil
Sanofi Pasteur, a Sanofi Company

Completed

Database Surveillance Safety Study of PENTACEL® Vaccine

Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae

United States

3

Subscribe